Airflow limitation as a risk factor for low bone mineral density and hip fracture

References

• Myers AH , Robinson EG , Van Natta ML , Michelson JD , Collins K , Baker SP. Hip fractures among elderly: factors associated with in-hospital mortality. Am J Epidemiol. 1991; 134: 1128–37.
   PubMed Web of Science ®Google Scholar
• Johnell O , Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17: 1726–33.
   PubMed Web of Science ®Google Scholar
• Kanis JA , Oden A , McCloskey EV , Johansson H , Wahl DA , Cooper C , IOF Working group on Epidemiology and Quality of Life . A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012; 23: 2239–56.
   PubMed Web of Science ®Google Scholar
• Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993; 94: 646–50.
   PubMed Web of Science ®Google Scholar
• Graat-Verboom L , Wouters EFM , Smeenk FWJM , Van Den Borne BEEM , Lunde R , Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J. 2009; 34: 209–18.
   PubMed Web of Science ®Google Scholar
• De Luise C , Brimacombe M , Pedersen L , Sørensen HT. Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol. 2008; 23: 115–22.
   PubMed Web of Science ®Google Scholar
• Romme EA, Geusens P, Lems WF, Rutten EP, Smeenk FW, Van Den Bergh JP, etal. Fracture prevention in COPD patients; a clinical 5-step approach. Respir Res. 2015; 16: 32. http://dx.doi.org/10.1186/s12931-015-0192-8.
   Google Scholar
• Kanis JA , Johnell O , Oden A , Johansson H , McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008; 19: 385–97.
   PubMed Web of Science ®Google Scholar
• Buist AS , McBurnie MA , Vollmer WM , Gillespie S , Burney P , Mannino DM , etal. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2012; 370: 741–50.
   Google Scholar
• Lehouck A , Boonen S , Decramer M , Janssens W. COPD, bone metabolism, and osteoporosis. Chest. 2011; 139: 648–57.
   PubMed Web of Science ®Google Scholar
• Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatiod arthritis. Rheumatology (Oxford). 2012; 51(Suppl 5): 3–11. http://dx.doi.org/10.1093/rheumatology/kes113.
   Google Scholar
• Moayyeri A , Bingham SA , Luben RN , Wareham NJ , Khaw KT. Respiratory function as a marker of bone health and fracture risk in an older population. J Bone Miner Res. 2009; 24: 956–63.
   PubMed Web of Science ®Google Scholar
• Kjensli A , Falch JA , Ryg M , Blenk T , Armbrecht G , Diep LM , etal. High prevalence of vertebral deformities in COPD patients: relationship to disease severity. Eur Respir J. 2009; 33: 1018–24.
   PubMed Web of Science ®Google Scholar
• Nuti R , Siviero P , Maggi S , Guglielmi G , Caffarelli C , Crepaldi G , etal. Vertebral fractures in patients with chronic obstructive disease: the EOLO Study. Osteoporos Int. 2009; 20: 989–98.
   PubMed Web of Science ®Google Scholar
• Nygaard O , Vollset SE , Refsum H , Stensvold I , Tverdal A , Nordrehaug JE , etal. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995; 274: 1526–33.
   Google Scholar
• Apalset, Gjesdal CG , Eide GE , Tell GS. Intake of vitamin K1 and K2 and risk of hip fractures: the Hordaland Health Study. Bone. 2011; 49: 990–5.
   PubMed Web of Science ®Google Scholar
• Gjesdal CG , Vollset SE , Ueland PM , Refsum H , Meyer HE , Tell GS. Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the Hordaland Homocysteine Study. J Bone Miner Res. 2007; 22: 747–56.
   Web of Science ®Google Scholar
• Pedersen AG, Ellingsen CL. Data quality in the Causes of Death Registry. Tidsskr Nor Laegeforen. 2015; 135(8): 768–70. http://dx.doi.org/10.4045/tidsskr.14.1065.
   Google Scholar
• GOLD. From the Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2008. Available from: http://www.goldcopd.org [cited 15 January 2012].
   Google Scholar
• Lehmann S , Vollset SE , Nygaard HA , Gulsvik A. Factors determining performance of bronchodilator reversibility test in middel-aged and elderly. Respir Med. 2004; 98: 1071–9.
   PubMed Web of Science ®Google Scholar
• ATS statement 1994. Standardization of spirometry. Am J Respir Crit Care Med. 1995; 152: 1107–36.
   Web of Science ®Google Scholar
• Gulsvik A , Tosteson T , Bakke P , Humerfelt S , Weiss ST , Speizer FE. Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. Clin Physiol. 2001; 21: 648–60.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2014). Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: http://www.goldcopd.org/ [cited 27 March 2014]..
   Google Scholar
• New GOLD guidelines: better than the old GOLD. Available from: http://pulmccm.org/main/2013/review-articles/new-gold-guidelines-2013-better-than-the-old-gold/ [cited 27 March 2014].
   Google Scholar
• The World Health Organization. Global database on body mass index. 1997. Available from: http://www.who.int/bmi [cited 27 March 2014]..
   Google Scholar
• Lehmann S , Bakke PS , Eide GE , Humerfelt S , Gulsvik A. Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to β2-agonist. Pulm Pharmacol Ther. 2006; 19: 272–80.
   PubMed Web of Science ®Google Scholar
• Stoller JK , Orens DK , Hoisington E , McCarthy K. Bedside spirometry in a tertiary care hospital: the Cleveland clinic experience. Respir Care. 2002; 47: 578–82.
   Google Scholar
• Enright PL , Johnson LR , Connett JE , Voelker H , Buist AS. Spirometry in the lung health study. 1. Methods and quality control. Am Rev Respir Dis. 1991; 143: 1215–23.
   PubMed Web of Science ®Google Scholar
• Rabe KF , Wedzicha JA , Wouters EFM. COPD and comorbidity. Eur Respir Monograph. 2013; 59: 93–104.
   Google Scholar
• Persson LJ , Aanerud M , Hiemstra PS , Hardie JA , Bakke PS , Eagan TM. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One. 2012; 7: e38934.
   PubMed Web of Science ®Google Scholar
• Looker AC. Relationships between femur neck bone mineral density and prevalent chronic obstructive pulmonary disease (COPD) or COPD mortality in older non-Hispanic white adults from NHANES III. Osteoporos Int. 2014; 25: 1043–52.
   Web of Science ®Google Scholar
• Eagan TM , Eide GE , Gulsvik A , Bakke PS. Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. J Clinc Epidemiol. 2002; 55: 775–81.
   Web of Science ®Google Scholar
• Thakur N , Blanc PD , Julian LJ , Yelin EH , Katz PP , Sidney S , etal. Eisner. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis. 2010; 5: 263–9.
   PubMedGoogle Scholar
• Mathur S , Takai KP , Macintyre DL , Reid D. Estimation of thigh muscle mass with magnetic resonance imaging in older adults and people with chronic obstructive pulmonary disease. Phys Ther. 2008; 88: 219–30.
   Web of Science ®Google Scholar
• Huang SW, Wang WT, Chou LC, Chen HC, Liou TH, Lin HW. Chronic obstructive pulmonary disease increases the risk of hip fracture: a nationwide population-based cohort study. Sci Rep. 2016; 6: 23360. http://dx.doi.org/10.1038/srep23360.
   Google Scholar
• Ferguson GT , Calverley PM , Anderson JA , Jenkins CR , Jones PW , Willits LR , etal. Prevalence and progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study. Chest. 2009; 136: 1456–65.
   PubMed Web of Science ®Google Scholar
• Graat-Verboom L , Van den Borne BE , Smeenk FW , Spruit MA , Wouters EF. Osteoporosis in COPD patients based on bone mineral density and vertebral fractures. J Bone Miner Res. 2011; 26: 561–8.
   PubMed Web of Science ®Google Scholar
• Kneidinger N , Yildirim AO , Callegari J , Takenaka S , Stein MM , Dumitrascu R , etal. Activation of the WNT/beta-catenin pathway attenuates experimental emphysema. Am J Respir Crit Care Med. 2011; 183: 723–33.
   PubMed Web of Science ®Google Scholar
• Bai P , Sun Y , Jin J , Hou J , Li R , Zhang Q , etal. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res. 2011; 12: 157.
   PubMed Web of Science ®Google Scholar
• Sinden NJ , Stockley RA. Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010; 65: 930–6.
   PubMed Web of Science ®Google Scholar
• MacNee W. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. Ann Med. 2013; 45: 291–300.
   PubMed Web of Science ®Google Scholar
• Hardy R , Cooper MS. Bone loss in inflammatory disorders. J Endocrinol. 2009; 201: 309–20.
   PubMed Web of Science ®Google Scholar
• Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damås JK, etal. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010; 35: 540–8. http://dx.doi.org/10.1183/09031936.00088209.
   Google Scholar
• Cotes JE. Lung function. Assessment and application in medicine. 1993; Oxford: Blackwell Scientific Publications. 5th ed.
   Google Scholar